Character Group PLC
10 October 2007
Issued on behalf of The Character Group plc, by Citigate Dewe Rogerson,
Birmingham
Date: Wednesday, 10 October 2007
IMMEDIATE RELEASE
The Character Group plc
('Group' or 'Character Group' or the 'Company')
Dream Toys 2007 List Has More Than A Touch of Character
Character Options, the trading subsidiary of Character Group, has an all-time
best three toys featured on the Toy Retailers Association (TRA) annual 'Dream
Toys' list, announced today.
The list is the only official prediction of Christmas 2007 best-sellers. In the
'Dream Dozen', Character has the following toys tipped for overall success:
• Doctor Who Dalek Sec Hybrid Voice Changer Mask
• Flytech Dragonfly
• GR8 Art Bindeez Super Deluxe Studio Centre
TRA has revealed six other categories, each listing 12 different products, five
of which feature Character Options toys and games:
• Boys: Dr Who Dalek Sec Hybrid Voice Changer Mask
Dr Who Figures Assortment
Stretch Power Ranger
• Pre-school: Peppa Pig Campervan Playset
• Games: Splashy the Whale Game
• Hip 'n Kool: Flytech Dragonfly
• Creative: Gr8 Art Bindeez Super Deluxe Studio
GR8 Scrapheap Welder
Richard King, Chairman, The Character Group said:
'We are extremely pleased to have accomplished our best ever performance on the
Dream Toys list, improving on last year's achievement when the Dr Who Cyberman
Mask appeared on the list.
'This recognition gives us confidence that the increase in market share that we
have enjoyed since the start of the year is likely to be maintained through the
important Christmas period.'
See www.toyretailersassociation.co.uk for further details on Dream Toys 2007.
Enquiries:
Richard King, Chairman Fiona Tooley, Director Richard Thompson
Kiran Shah, Group Finance Keith Gabriel, Senior Account Manager Philip Davies
Director and Joint Managing Director
The Character Group plc Citigate Dewe Rogerson Charles Stanley Securities
Tel: +44 (0) 20 8949 5898 Tel: +44 (0) 121 455 8370 Nominated Adviser
Mobile: +44 (0) 7836 250150 (RK) Mobile: +44 (0) 7785 703523 (FMT) Tel: +44 (0) 20 7149 6000
Notes to Editors:
AIM listed, The Character Group Plc (Ticker: CCT.L) designs, develops, markets
and distributes toys and games, principally to the UK market although it has an
increasing exposure to the international market.
The Group operates mainly in the United Kingdom and China, and has offices in
London, Oldham, Hong Kong and Shenzhen, China. It employs around 225 people
worldwide.
Revenues are generated from a mix of product ranges with over 70% designed and
developed in-house either under the Group's own brand or under licences with the
balance being derived from third-party distribution. Products are now sold in
over 30 countries.
Notable product lines within the Character portfolio are Doctor Who, Scooby Doo,
Disney Princess, Peppa Pig, Barney, Gr8 Gear, Wow Wee Robotics (including
Robosapien). For a more comprehensive view of the product portfolio, visit
www.character-online.com.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.